Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-022457
Filing Date
2025-02-18
Accepted
2025-02-18 17:10:58
Documents
113
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K axsm-20241231.htm   iXBRL 10-K 3812202
2 EX-19.1 axsm-ex19_1.htm EX-19.1 143288
3 EX-21.1 axsm-ex21_1.htm EX-21.1 8722
4 EX-23.1 axsm-ex23_1.htm EX-23.1 4938
5 EX-23.2 axsm-ex23_2.htm EX-23.2 12673
6 EX-31.1 axsm-ex31_1.htm EX-31.1 18627
7 EX-31.2 axsm-ex31_2.htm EX-31.2 18157
8 EX-32.1 axsm-ex32_1.htm EX-32.1 6804
9 EX-32.2 axsm-ex32_2.htm EX-32.2 6803
10 GRAPHIC img241169083_0.jpg GRAPHIC 2514777
11 GRAPHIC img241169083_1.jpg GRAPHIC 293388
  Complete submission text file 0000950170-25-022457.txt   21729974

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT axsm-20241231.xsd EX-101.SCH 2070175
116 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20241231_htm.xml XML 2860269
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37635 | Film No.: 25636079
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)